Human embryonic stem cells suppress T cell responses via arginase I-dependent mechanism

Journal of Immunology

Volumn 184, Issue 3, 2010, Pages 1300-1308

  Yachimovich Cohen, Nurit ^a   Even Ram, Sharona ^a   Shufaro, Yoel ^a   Rachmilewitz, Jacob ^a   Reubinoff, Benjamin ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; ARGININE; CD3 ANTIGEN; T LYMPHOCYTE RECEPTOR; ZETA GLOBIN; ANTIGEN T CELL RECEPTOR, ZETA CHAIN; ARGINASE; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; ANIMAL CELL; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ECTODERM; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; INNER CELL MASS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PHYSIOLOGY; SECRETION; T LYMPHOCYTE SUBPOPULATION; TERATOMA; TRANSPLANTATION;

ADULT; ANIMALS; ANTIGENS, CD3; ARGINASE; ARGININE; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; TERATOMA;

EID: 77949331434     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804261     Document Type: Article

References (27)

1. Reubinoff, B. E., M. F. Pera, C. Y. Fong, A. Trounson, and A. Bongso. 2000. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18: 399-404.
2. Thomson, J. A., J. Itskovitz-Eldor, S. S. Shapiro, M. A. Waknitz, J. J. Swiergiel, V. S. Marshall, and J. M. Jones. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
3. Fändrich, F., X. Lin, G. X. Chai, M. Schulze, D. Ganten, M. Bader, J. Holle, D. S. Huang, R. Parwaresch, N. Zavazava, and B. Binas. 2002. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat. Med. 8: 171-178.
4. Bonde, S., and N. Zavazava. 2006. Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24: 2192-2201.
5. Li, L., M. L. Baroja, A. Majumdar, K. Chadwick, A. Rouleau, L. Gallacher, I. Ferber, J. Lebkowski, T. Martin, J. Madrenas, and M. Bhatia. 2004. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22: 448-456.
6. Drukker, M., H. Katchman, G. Katz, S. Even-Tov Friedman, E. Shezen, E. Hornstein, O. Mandelboim, Y. Reisner, and N. Benvenisty. 2006. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24: 221-229.
7. Magliocca, J. F., I. K. Held, and J. S. Odorico. 2006. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev. 15: 707-717.
8. Swijnenburg, R. J., S. Schrepfer, J. A. Govaert, F. Cao, K. Ransohoff, A. Y. Sheikh, M. Haddad, A. J. Connolly, M. M. Davis, R. C. Robbins, and J. C. Wu. 2008. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. U.S.A. 105: 12991-12996.
9. Trigona, W. L., C. M. Porter, J. A. Horvath-Arcidiacono, A. S. Majumdar, and E. T. Bloom. 2007. Could heme-oxygenase-1 have a role in modulating the recipient immune response to embryonic stem cells? Antioxid. Redox Signal. 9: 751-756.
10. Drukker, M., G. Katz, A. Urbach, M. Schuldiner, G. Markel, J. Itskovitz-Eldor, B. Reubinoff, O. Mandelboim, and N. Benvenisty. 2002. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 99: 9864-9869.
11. Rodriguez, P. C., D. G. Quiceno, J. Zabaleta, B. Ortiz, A. H. Zea, M. B. Piazuelo, A. Delgado, P. Correa, J. Brayer, E. M. Sotomayor, et al. 2004. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64: 5839-5849.
12. Rodriguez, P. C., A. H. Zea, K. S. Culotta, J. Zabaleta, J. B. Ochoa, and A. C. Ochoa. 2002. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J. Biol. Chem. 277: 21123-21129.
13. Rodriguez, P. C., A. H. Zea, J. DeSalvo, K. S. Culotta, J. Zabaleta, D. G. Quiceno, J. B. Ochoa, and A. C. Ochoa. 2003. L-arginine consumption by macrophages modulates the expression of CD3 ζ chain in T lymphocytes. J. Immunol. 171: 1232-1239.
14. Hogan, B., F. Constantini, and E. Lacey. 1986. Manipulating the Mouse Embryo. 92-94.
15. Even-Ram, S. 2009. Fibrin gel model for assessment of cellular contractility. Methods Mol. Biol. 522: 251-259.
16. Xu, R. H., X. Chen, D. S. Li, R. Li, G. C. Addicks, C. Glennon, T. P. Zwaka, and J. A. Thomson. 2002. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol. 20: 1261-1264.
17. Inzunza, J., K. Gertow, M. A. Strömberg, E. Matilainen, E. Blennow, H. Skottman, S. Wolbank, L. Ahrlund-Richter, and O. Hovatta. 2005. Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23: 544-549.
18. Bronte, V., and P. Zanovello. 2005. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5: 641-654.
19. Krebs, H. A. 1942. Urea formation in mammalian liver. Biochem. J. 36: 758-767.
20. Takahashi, A., K. Kono, H. Amemiya, H. Iizuka, H. Fujii, and Y. Matsumoto. 2001. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR ζ molecules in patients with gastric cancer. Clin. Cancer Res. 7: 74-80.
21. Baniyash, M. 2004. TCR z-chain downregulation: curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 4: 675-687.
22. Koch, C. A., P. Geraldes, and J. L. Platt. 2008. Immunosuppression by embryonic stem cells. Stem Cells 26: 89-98.
23. Kim, P. S., R. K. Iyer, K. V. Lu, H. Yu, A. Karimi, R. M. Kern, D. K. Tai, S. D. Cederbaum, and W. W. Grody. 2002. Expression of the liver form of arginase in erythrocytes. Mol. Genet. Metab. 76: 100-110.
24. Ishikawa, T., T. Harada, H. Koi, T. Kubota, H. Azuma, and T. Aso. 2007. Identification of arginase in human placental villi. Placenta 28: 133-138.
25. Kropf, P., D. Baud, S. E. Marshall, M. Munder, A. Mosley, J. M. Fuentes, C. R. Bangham, G. P. Taylor, S. Herath, B. S. Choi, et al. 2007. Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur. J. Immunol. 37: 935-945.
26. Popovic, P. J., H. J. Zeh, 3rd, and J. B. Ochoa. 2007. Arginine and immunity. J. Nutr. 137(6, Suppl 2)1681S-1686S.
27. Brunlid, G., J. Pruszak, B. Holmes, O. Isacson, and K. C. Sonntag. 2007. Immature and neurally differentiated mouse embryonic stem cells do not express a functional Fas/Fas ligand system. Stem Cells 25: 2551-2558.